170 related articles for article (PubMed ID: 20371707)
21. Tracheal relaxing effects and beta2 adrenoceptor selectivity of S1319, a novel sponge-derived bronchodilator agent, in isolated guinea-pig tissues.
Suzuki H; Ueno A; Takei M; Sindo K; Miura T; Sakakibara M; Higa T; Fukamachi H
Br J Pharmacol; 1999 Oct; 128(3):716-20. PubMed ID: 10516653
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological Profile of AZD8871 (LAS191351), a Novel Inhaled Dual M
Aparici M; Carcasona C; Ramos I; Montero JL; Otal R; Ortiz JL; Cortijo J; Puig C; Vilella D; De Alba J; Doe C; Gavaldà A; Miralpeix M
J Pharmacol Exp Ther; 2019 Jul; 370(1):127-136. PubMed ID: 31085697
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and structure-activity relationships of long-acting beta2 adrenergic receptor agonists incorporating arylsulfonamide groups.
Procopiou PA; Barrett VJ; Bevan NJ; Biggadike K; Butchers PR; Coe DM; Conroy R; Edney DD; Field RN; Ford AJ; Guntrip SB; Looker BE; McLay IM; Monteith MJ; Morrison VS; Mutch PJ; Richards SA; Sasse R; Smith CE
J Med Chem; 2009 Apr; 52(8):2280-8. PubMed ID: 19317397
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological preclinical characterization of LAS190792, a novel inhaled bifunctional muscarinic receptor antagonist /β
Aparici M; Carcasona C; Ramos I; Montero JL; Ortiz JL; Cortijo J; Puig C; Vilella D; Doe C; Gavaldà A; Miralpeix M
Pulm Pharmacol Ther; 2017 Oct; 46():1-10. PubMed ID: 28729041
[TBL] [Abstract][Full Text] [Related]
25. Tiotropium sustains the anti-inflammatory action of olodaterol via the cyclic AMP pathway.
Costa L; Roth M; Miglino N; Keglowich L; Zhong J; Lardinois D; Tamm M; Borger P
Pulm Pharmacol Ther; 2014 Feb; 27(1):29-37. PubMed ID: 24269928
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological characterization of the interaction between tiotropium and olodaterol administered at 5:5 concentration-ratio in equine bronchi.
Calzetta L; Rogliani P; Mattei M; Alfonsi P; Cito G; Pistocchini E; Cazzola M; Matera MG
COPD; 2017 Oct; 14(5):526-532. PubMed ID: 28745522
[TBL] [Abstract][Full Text] [Related]
27. GW427353 (solabegron), a novel, selective beta3-adrenergic receptor agonist, evokes bladder relaxation and increases micturition reflex threshold in the dog.
Hicks A; McCafferty GP; Riedel E; Aiyar N; Pullen M; Evans C; Luce TD; Coatney RW; Rivera GC; Westfall TD; Hieble JP
J Pharmacol Exp Ther; 2007 Oct; 323(1):202-9. PubMed ID: 17626794
[TBL] [Abstract][Full Text] [Related]
28. Discovery of a rapidly metabolized, long-acting β(2) adrenergic receptor agonist with a short onset time incorporating a sulfone group suitable for once-daily dosing.
Procopiou PA; Barrett VJ; Biggadike K; Butchers PR; Craven A; Ford AJ; Guntrip SB; Holmes DS; Hughes SC; Jones AE; Looker BE; Mutch PJ; Ruston M; Needham D; Smith CE
J Med Chem; 2014 Jan; 57(1):159-70. PubMed ID: 24359185
[TBL] [Abstract][Full Text] [Related]
29. Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses.
Ryall JG; Sillence MN; Lynch GS
Br J Pharmacol; 2006 Mar; 147(6):587-95. PubMed ID: 16432501
[TBL] [Abstract][Full Text] [Related]
30. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
[TBL] [Abstract][Full Text] [Related]
31. Preclinical evaluation of long-acting muscarinic antagonists: comparison of tiotropium and investigational drugs.
Casarosa P; Bouyssou T; Germeyer S; Schnapp A; Gantner F; Pieper M
J Pharmacol Exp Ther; 2009 Aug; 330(2):660-8. PubMed ID: 19478135
[TBL] [Abstract][Full Text] [Related]
32. Olodaterol for the treatment of asthma.
Cazzola M; Rinaldi B; Lucà G; Ora J
Expert Opin Investig Drugs; 2016 Jul; 25(7):861-6. PubMed ID: 27170011
[TBL] [Abstract][Full Text] [Related]
33. Long- and short-acting beta2 adrenoceptor agonists: interactions in human contracted bronchi.
Molimard M; Naline E; Zhang Y; Le Gros V; Begaud B; Advenier C
Eur Respir J; 1998 Mar; 11(3):583-8. PubMed ID: 9596106
[TBL] [Abstract][Full Text] [Related]
34. Use of 5-hydroxy-4H-benzo[1,4]oxazin-3-ones as beta2-adrenoceptor agonists.
Hoenke C; Bouyssou T; Tautermann CS; Rudolf K; Schnapp A; Konetzki I
Bioorg Med Chem Lett; 2009 Dec; 19(23):6640-4. PubMed ID: 19875286
[TBL] [Abstract][Full Text] [Related]
35. Beta2-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting beta2-agonist therapy.
Lipworth BJ; Hall IP; Aziz I; Tan KS; Wheatley A
Clin Sci (Lond); 1999 Mar; 96(3):253-9. PubMed ID: 10029561
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological effect of TRK-380, a novel selective human β3-adrenoceptor agonist, on mammalian detrusor strips.
Kanie S; Otsuka A; Yoshikawa S; Morimoto T; Hareyama N; Okazaki S; Kobayashi R; Hasebe K; Nakao K; Hayashi R; Mochizuki H; Matsumoto R; Ozono S
Urology; 2012 Mar; 79(3):744.e1-7. PubMed ID: 22197203
[TBL] [Abstract][Full Text] [Related]
37. Relaxant effects and durations of action of formoterol and salmeterol on the isolated human bronchus.
Naline E; Zhang Y; Qian Y; Mairon N; Anderson GP; Grandordy B; Advenier C
Eur Respir J; 1994 May; 7(5):914-20. PubMed ID: 7914176
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological Characterization of a Novel 5-Hydroxybenzothiazolone-Derived
Koziczak-Holbro M; Rigel DF; Dumotier B; Sykes DA; Tsao J; Nguyen NH; Bösch J; Jourdain M; Flotte L; Adachi Y; Kiffe M; Azria M; Fairhurst RA; Charlton SJ; Richardson BP; Lach-Trifilieff E; Glass DJ; Ullrich T; Hatakeyama S
J Pharmacol Exp Ther; 2019 May; 369(2):188-199. PubMed ID: 30819762
[TBL] [Abstract][Full Text] [Related]
39. Positive interaction of the beta2-agonist CHF 4226.01 with budesonide in the control of bronchoconstriction induced by acetaldehyde in the guinea-pigs.
Rossoni G; Manfredi B; Razzetti R; Civelli M; Bongrani S; Berti F
Br J Pharmacol; 2005 Feb; 144(3):422-9. PubMed ID: 15655502
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases.
Salmon M; Luttmann MA; Foley JJ; Buckley PT; Schmidt DB; Burman M; Webb EF; DeHaas CJ; Kotzer CJ; Barrett VJ; Slack RJ; Sarau HM; Palovich MR; Lainé DI; Hay DW; Rumsey WL
J Pharmacol Exp Ther; 2013 May; 345(2):260-70. PubMed ID: 23435542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
